Table 1.
Baseline patient characteristics.
| Variables | All Patients (Total, N=70) | Diabetic PAD Patients (N=27) | Non-Diabetic PAD Patients (N=43) | P-value |
|---|---|---|---|---|
|
| ||||
| Age (years) | 63.15 ± 6.33 | 62.49 ± 6.08 | 63.56 ± 6.5 | 0.92 |
| Male sex, n (%) | 64 (91.43) | 24 (34.29) | 40 (57.14) | 0.67 |
| Black race, n (%) | 13 (18.57) | 4 (5.71) | 9 (12.86) | 0.52 |
| Body mass index (kg/m²) | 29.9 (25.2, 35.5) | 31.3 (28.5, 39) | 27.7 (23.8, 33.8) | 0.051 |
| Aspirin, n (%) | 69 (98.57) | 27 (38.57) | 42 (60.00) | 1.00 |
| Statin, n (%) | 68 (97.14) | 26 (37.14) | 42 (60.00) | 1.00 |
| Current smoking, n (%) | 32 (45.71) | 9 (12.86) | 23 (32.86) | 0.10 |
| Diabetes mellitus, n (%) | 27 (38.57) | 13 (18.57) | 14 (20.00) | 0.53 |
| Hypertension, n (%) | 57 (81.43) | 23 (32.86) | 34 (48.57) | 0.52 |
| Hyperlipidemia, n (%) | 64 (95.52) | 24 (35.82) | 40 (59.70) | 1.00 |
| Coronary artery disease, n (%) | 21 (32.31) | 10 (15.38) | 11 (16.92) | 0.22 |
| History of revascularization, n (%) | 27 (38.57) | 10 (14.29) | 17 (24.29) | 0.83 |
| Triglyceride (mg /dl) | 134.0 (80) | 145 (102, 192) | 128 (95, 177) | 0.63 |
| Non-HDL cholesterol (mg /dl) | 123.5 (100, 152) | 113 (84, 164) | 130 (109, 151) | 0.28 |
| LDL cholesterol (mg /dl) | 96.0 (73, 121) | 84.50 (61, 126) | 101 (79, 120) | 0.18 |
| HDL cholesterol (mg /dl) | 40.5 (34, 47) | 35.0 (32, 47) | 42 (35, 47) | 0.11 |
| C-reactive protein (mg /dl) | 3.0 (1.7, 5.4) | 4.26 (1.9, 8.08) | 279 (1.7, 4.7) | 0.08 |
| Total cholesterol (mg /dl) | 168.0 (137, 200) | 157.73 (127, 200) | 173 (146, 200) | 0.18 |
Values are reported as mean (standard deviation), medians and interquartile range (IQR), and as frequencies (percentage). PAD: peripheral artery disease. For hyperlipidemia, LDL cholesterol, and coronary artery disease: total n=26.